Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: Behavioral, endocrine and neurochemical effects in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 2, 2000, Pages 588-597

  Arborelius, Lotta ^a   Skelton, Kelly H ^a   Thrivikraman, Karacheri V ^a   Plotsky, Paul M ^a   Schulz, David W ^b   Owens, Michael J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MESSENGER RNA; UROCORTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; ENDOCRINE SYSTEM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR BINDING; THALAMUS MIDLINE NUCLEUS;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; BRAIN; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DRUG ADMINISTRATION SCHEDULE; ENDOCRINE SYSTEM; MALE; ORGAN SIZE; PYRIMIDINES; PYRROLES; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA, MESSENGER; STARTLE REACTION; STRESS;

EID: 0033913770     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Arborelius L, Owens MJ, Plotsky PM and Nemeroff CB (1999) The role of corticotropin-releasing factor (CRF) in depression and anxiety disorders. J Endocrinol 160:1-12.
2. Bornstein SR, Webster EL, Torpy DJ, Richman SJ, Mitsiades N, Igel M, Lewis DB, Rice KC, Joost HG, Tsokos M and Chrousos GP (1998) Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. Endocrinology 139: 1546-1555.
3. Butler PD, Weiss JM, Stout JC and Nemeroff CB (1990) Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus. J Neurosci 10:176-183.
4. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP and De Souza EB (1996) Corticotropin-releasing factor receptors: From molecular biology to drug design. Trends Pharmacol Sci 17:166-172.
5. Chappell PB, Smith MA, Kilts CD, Bissette G, Ritchie J, Erson C and Nemeroff CB (1986) Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J Neurosci 6:2908-2914.
6. Chen YL, Mansbach RS, Winter SM, Brooks E, Collins J, Corman ML, Dunaiskis AR, Faraci WS, Gallaschun RJ, Schmidt A and Schulz DW (1997) Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: A centrally active corticotropin-releasing factor 1 receptor antagonist. J Med Chem 40:1749-1754.
7. Deak T, Nguyen KT, Ehrlich AL, Watkins LR, Spencer RL, Maier SF, Licinio J, Wong M-L, Chrousos GP, Webster E and Gold PW (1999) The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology 140:79-86.
8. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM and Vale WW (1996a) Cloning and characterization of human urocortin. Endocrinology 137:2167-2170.
9. Donaldson CJ, Sutton SW, Perrin MH, Corrigan AZ, Lewis KA, Rivier JE, Vaughan JM and Vale WW (1996b) Erratum. Endocrinology 137:3896.
10. Engelmann M, Thrivikraman KV, Su Y, Nemeroff CB, Montkowski A, Landgraf R, Holsboer F and Plotsky PM (1996) Psychoneuroendocrinology 21:391-400.
11. Griebel G, Perrault G and Sanger DJ (1998) Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents: Comparison with diazepam and buspirone. Psychopharmacology 138: 55-66.
12. Hauger RL, Millan MA, Lorang M, Harwood JP and Aguilera G (1988) Corticotropin-releasing factor receptors and pituitary-adrenal responses during immobilization stress. Endocrinology 123:396-405.
13. 2, receptors mediate anxiogenic-like behavior. Regul Pept 71:15-21.
14. Holsboer F (1999) Clinical neuroendocrinology, in Neurobiology of Mental Illness (Charney DS, Nestler EJ and Bunney BS eds) pp 149-161, Oxford University Press, New York.
15. Imaki T, Naruse M, Harada S, Chikada N, Imaki J, Onodera H, Demura H and Vale W (1996) Corticotropin-releasing factor up-regulates its own receptor mRNA in the paraventricular nucleus of the hypothalamus. Brain Res Mol Brain Res 38:166-170.
16. Ladd CO, Owens MJ and Nemeroff CB (1996) Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation. Endocrinology 137:1212-1218.
17. Liebsch G, Landgraf R, Engelmann P, Lorscher P and Holsboer F (1999) Chronic infusion of CRH1 or CRH2 receptor antisense oligonucleotides into the rat brain differentially affects emotional and stress coping behavior. J Psychiatr Res 33: 153-163.
18. 1 receptor anti-sense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Pept 59:229-239.
19. Lundkvist J, Chai Z, Teheranian R, Hasanvan H, Bartfai T, Jenck F, Widmer U and Moreau J-L (1996) A non peptide corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. Eur J Pharmacol 309:195-200.
20. 1 receptor antagonist. Eur J Pharmacol 323:21-26.
21. Owens MJ and Nemeroff CB (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43:425-473.
22. Owens MJ and Nemeroff CB (1999) Corticotropin-releasing factor antagonists in affective disorders. Exp Opin Invest Drugs 8:1849-1858.
23. Owens MJ, Nemeroff CB and Bissette G (1999) Neuropeptides: Biology and regulation, in Comprehensive Textbook of Psychiatry/VII (Sadock BJ and Sadock VA eds) pp 60-70, Lippincott Williams & Wilkins, Baltimore, MD.
24. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Harcourt Brace Jovanovich, San Diego, CA.
25. Plotsky PM, Owens MJ and Nemeroff CB (1998) Psychoneuroendocrinology of depression: Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 21:293-307.
26. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ and Swaab DF (1994) Increased number of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Clin Neuroendocrinol 60: 436-444.
27. Raadsheer FC, Van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ and Swaab DF (1995) Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 152:1372-1376.
28. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seeger T, Seymour P, Tingley FD III, Winston EN, Chen YL and Heym J (1996) CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 93:10477-10482.
29. Simmons DM, Arriza JL and Swanson LW (1989) A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radiolabeled single-stranded RNA probes. J Histotechnol 12:169-181.
30. Skelton KH, Nemeroff CB, Knight DL and Owens MJ (2000) Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. J Neurosci 20:1240-1248.
31. Smagin GN, Harros RB and Ryan DH (1996) Corticotropin-releasing factor receptor antagonist infused into the locus ceruleus attenuates immobilization stress-induced defensive withdrawal in rats. Neurosci Lett 220:167-170.
32. Smart D, Coppell A, Rossant C, Hall M and McKnight AT (1999) Characterisation using microphysiometry of CRF receptor pharmacology. Eur J Pharmacol 379: 229-235.
33. Smith GW, Aubry J-M, Dellu F, Contarino A, Bilezikjian LM, Gold LH, Chen R, Marchuk Y, Hauser C, Bentley CA, Sawchenko PE, Koob GF, Vale W and Lee K-F (1998) Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20:1093-1102.
34. Swiergiel AH, Takahashi LK and Kalin NH (1993) Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res 623:229-234.
35. Takahashi LK, Kalin NH, Vanden Burgt JA and Sherman JE (1989) Corticotropin-releasing factor modulates defensive-withdrawal and exploratory behavior in rats. Behav Neurosci 103:648-654.
36. Thrivikraman KV and Plotsky PM (1993) Absence of glucocorticoid negative feedback to moderate hemorrhage in conscious rats. Am J Physiol 264:E497-E503.
37. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JMHM, Stalla GK, Blanquet V, Steckler T, Holsboer F and Wurst W (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 19:162-166.
38. Valentino RJ, Chen S, Zhu Y and Aston-Jones G (1996) Evidence for divergent projections to the brain noradrenergic system and the spinal parasympathetic system from Barrington's nucleus. Brain Res 732:1-15.
39. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE and Vale W (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature (Lond) 378:287-292.
40. Webster EL, Lewis DB, Torpy DJ, Zachman EK, Rice KC and Chrousos GP (1996) In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropinreleasing hormone (CRH) antagonist: Suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137:5747-5750.
41. Wong M-L, Al-Shekkhlee A, Bongiorno PB, Esposito A, Khatri P, Sternberg EM, Gold PW and Licinio J (1996) Localization of urocortin messenger RNA in rat brain and pituitary. Mol Psychiatry 1:307-312.